Status:
COMPLETED
Exoskeleton Rehabilitation on TBI
Lead Sponsor:
DHR Health Institute for Research and Development
Conditions:
Traumatic Brain Injury
Cerebral Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Background: Traumatic brain injury (TBI) is one of the leading causes of disability in the United States. The EKSO GT Bionics® (EKSO®) is a robotic exoskeleton approved by the Federal Drug Administrat...
Detailed Description
Study Design and Setting This is an observational, retrospective, chart review cohort study of patients from a private single rehabilitation hospital. Study approval was granted by the local Institut...
Eligibility Criteria
Inclusion
- Main indications for the use of the EKSO® during rehabilitation included a height range between 1.56 to 1.9 meters and a patient's weight equal to or less than 100kg.
- Stable blood pressure was required, with the ability to follow one to two steps commands, and the patient should also have demonstrated a normal range of motion in hips, knees, and ankles.
- Patient must have suffered a traumatic brain injury or stroke
Exclusion
- Patients were excluded if their injury type was outside the scope of the current study.
Key Trial Info
Start Date :
September 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT04465019
Start Date
September 25 2019
End Date
December 31 2020
Last Update
May 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DHR Health Rehabilitation Hospital
Edinburg, Texas, United States, 78539